Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
285
-
Total 13F shares, excl. options
-
50.9M
-
Shares change
-
-1.39M
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
-$59.1M
-
Put/Call ratio
-
3.53
-
Number of buys
-
117
-
Number of sells
-
-144
-
Price
-
$26.55
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2021
389 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2021.
Editas Medicine, Inc. - Common Stock (EDIT) has 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.9M shares
of 82.8M outstanding shares and own 61.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.67M shares), BlackRock Inc. (5.43M shares), ARK Investment Management LLC (4.22M shares), STATE STREET CORP (3.27M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.68M shares), Nikko Asset Management Americas, Inc. (2.68M shares), JPMORGAN CHASE & CO (1.46M shares), GEODE CAPITAL MANAGEMENT, LLC (1.22M shares), VICTORY CAPITAL MANAGEMENT INC (1.12M shares), and Capital World Investors (1.1M shares).
This table shows the top 285 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.